Skip to main content
. 2013 May 3;13:223. doi: 10.1186/1471-2407-13-223

Figure 1.

Figure 1

Cancer-specific survival (Kaplan-Meier) of patients with penile SCC plotted against the preoperative CRP group. The 5-year survival rate of all evaluable patients (n=69) was 84.3% for CRP ≤15 mg/l (n=54) and 38.9% for CRP >15 mg/l (n=15) (p=0.001, log rank).